Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trial.
Lancet Oncol. 2019 Aug;20(8):1136-1147. doi: 10.1016/S1470-2045(19)30275-X. Epub 2019 Jun 17.
Lancet Oncol. 2019.
PMID: 31221620
Clinical Trial.
Cost-effectiveness of Breast Cancer Screening With Magnetic Resonance Imaging for Women at Familial Risk.
Geuzinge HA, Obdeijn IM, Rutgers EJT, Saadatmand S, Mann RM, Oosterwijk JC, Tollenaar RAEM, de Roy van Zuidewijn DBW, Lobbes MBI, van 't Riet M, Hooning MJ, Ausems MGEM, Loo CE, Wesseling J, Luiten EJT, Zonderland HM, Verhoef C, Heijnsdijk EAM, Tilanus-Linthorst MMA, de Koning HJ; Familial MRI Screening (FaMRIsc) Study group.
Geuzinge HA, et al.
JAMA Oncol. 2020 Sep 1;6(9):1381-1389. doi: 10.1001/jamaoncol.2020.2922.
JAMA Oncol. 2020.
PMID: 32729887
Free PMC article.
Item in Clipboard
Experiences, expectations and preferences regarding MRI and mammography as breast cancer screening tools in women at familial risk.
Geuzinge HA, Heijnsdijk EAM, Obdeijn IM, de Koning HJ, Tilanus-Linthorst MMA; FaMRIsc study group.
Geuzinge HA, et al.
Breast. 2021 Apr;56:1-6. doi: 10.1016/j.breast.2021.01.002. Epub 2021 Jan 18.
Breast. 2021.
PMID: 33515770
Free PMC article.
Item in Clipboard
Cost-Effectiveness of Magnetic Resonance Imaging Screening for Women With Extremely Dense Breast Tissue.
Geuzinge HA, Bakker MF, Heijnsdijk EAM, van Ravesteyn NT, Veldhuis WB, Pijnappel RM, de Lange SV, Emaus MJ, Mann RM, Monninkhof EM, de Koekkoek-Doll PK, van Gils CH, de Koning HJ; DENSE trial study group.
Geuzinge HA, et al.
J Natl Cancer Inst. 2021 Nov 2;113(11):1476-1483. doi: 10.1093/jnci/djab119.
J Natl Cancer Inst. 2021.
PMID: 34585249
Free PMC article.
Item in Clipboard
Breast Cancer Screening Strategies for Women With ATM, CHEK2, and PALB2 Pathogenic Variants: A Comparative Modeling Analysis.
Lowry KP, Geuzinge HA, Stout NK, Alagoz O, Hampton J, Kerlikowske K, de Koning HJ, Miglioretti DL, van Ravesteyn NT, Schechter C, Sprague BL, Tosteson ANA, Trentham-Dietz A, Weaver D, Yaffe MJ, Yeh JM, Couch FJ, Hu C, Kraft P, Polley EC, Mandelblatt JS, Kurian AW, Robson ME; Breast Working Group of the Cancer Intervention and Surveillance Modeling Network (CISNET), in collaboration with the Breast Cancer Surveillance Consortium (BCSC), and the Cancer Risk Estimates Related to Susceptibility (CARRIERS) Consortium.
Lowry KP, et al. Among authors: geuzinge ha.
JAMA Oncol. 2022 Apr 1;8(4):587-596. doi: 10.1001/jamaoncol.2021.6204.
JAMA Oncol. 2022.
PMID: 35175286
Free PMC article.
Item in Clipboard
Effects of a leaflet on breast cancer screening knowledge, explicit attitudes, and implicit associations.
Kregting LM, van Ravesteyn NT, Spijker W, Dierks T, Aitken CA, Geuzinge HA, Korfage IJ.
Kregting LM, et al. Among authors: geuzinge ha.
Patient Educ Couns. 2020 Jul 2:S0738-3991(20)30350-5. doi: 10.1016/j.pec.2020.06.032. Online ahead of print.
Patient Educ Couns. 2020.
PMID: 32732022
Free article.
Item in Clipboard
Interval post-colonoscopy colorectal cancer following a negative colonoscopy in a fecal immunochemical test-based screening program.
van de Schootbrugge-Vandermeer HJ, Kooyker AI, Wisse PHA, Nagtegaal ID, Geuzinge HA, Toes-Zoutendijk E, de Jonge L, Breekveldt ECH, van Vuuren AJ, van Kemenade FJ, Ramakers CRB, Dekker E, Lansdorp-Vogelaar I, Spaander MCW, van Leerdam ME.
van de Schootbrugge-Vandermeer HJ, et al. Among authors: geuzinge ha.
Endoscopy. 2023 Dec;55(12):1061-1069. doi: 10.1055/a-2136-6564. Epub 2023 Oct 4.
Endoscopy. 2023.
PMID: 37793423
Free PMC article.
Item in Clipboard
Cite
Cite